Literature DB >> 16565699

[Benefit from bio-enteric Intra-gastric balloon (BIB) to modify lifestyle and eating habits in severely obese patients eligible for bariatric surgery].

S Zago1, A M Kornmuller, D Agagliati, B Saber, D Ferrari, P Maffeis, M Labate, E Bauducco, L Manghisi, L Martignone, M Spanu, G M Rovera.   

Abstract

AIM: The therapeutic model for severe obesity includes bariatric surgery, representing the safest way to keep weight down and to prevent relapses. The selection of patients for the most suitable type of surgery implies multidisciplinary approach (nutritionist, dietist, clinical psychologist and surgeon). The intragastric balloon may represent a relatively invasive method to help the medical team to select and prepare severely obese patients for restrictive bariatric surgery.
METHODS: In our study we considered 48 severely obese patients: initial weight 111+/-14.8 kg, BMI 43+/-5.02, excess weight 77.47+/-16.14%. These patients have been treated with intragastric balloon (BIB) filled to a volume of 500 cc for 6 months. We considered variations induced by BIB treatment on a number of parameters--clinical, anthropometric, food intake, partition of nourishing elements and psychological and psychometric data.
RESULTS: At the end of the treatment the patients showed significant reductions of excess weight (67.35+/-20.19%), of weight (103.4+/-16.72 kg) and food intake, without modification of the items in the EDI2 test, but with important motivational support for a change in life style between the beginning and the end of the treatment, clearly resulting from the medical, dietist and clinical-psychological follow-up.
CONCLUSIONS: BIB is a relatively invasive means capable of modifying eating habits in the short term; it induces weight loss, may help to reduce the anaesthesiological risk and to foster a change in the patient's behaviour. In our experience treatment with BIB is useful from the educational point of view and can be used to select patients for bariatric surgery only within a multidisciplinary team. Further clinical studies are necessary.

Entities:  

Mesh:

Year:  2006        PMID: 16565699

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  5 in total

1.  Single vs repeated treatment with the intragastric balloon: a 5-year weight loss study.

Authors:  Jean-Marc Dumonceau; Erik François; Axel Hittelet; Abdel Ilah Mehdi; Marie Barea; Jacques Deviere
Journal:  Obes Surg       Date:  2010-06       Impact factor: 4.129

2.  Intragastric balloon treatment of obesity: Long-term results and patient satisfaction.

Authors:  Aline El Haddad; Mohammad O Rammal; Assaad Soweid; Ala I Shararra; Fady Daniel; Mahmoud A Rahal; Yasser Shaib
Journal:  Turk J Gastroenterol       Date:  2019-05       Impact factor: 1.852

3.  Intragastric balloon treatment for obesity: results of a large single center prospective study.

Authors:  Davor Stimac; Sanja Klobučar Majanović; Tamara Turk; Borivoj Kezele; Vanja Licul; Zeljka Crnčević Orlić
Journal:  Obes Surg       Date:  2011-05       Impact factor: 4.129

4.  Tolerance and efficacy of an air-filled balloon in non-morbidly obese patients: results of a prospective multicenter study.

Authors:  François Mion; Rodica Gincul; Sabine Roman; Sylvain Beorchia; Frank Hedelius; Nicolas Claudel; Roger-Michel Bory; Etienne Malvoisin; Frédérique Trepo; Bertrand Napoleon
Journal:  Obes Surg       Date:  2007-06       Impact factor: 4.129

5.  Impact of a 6-month treatment with intragastric balloon on body composition and psychopathological profile in obese individuals with metabolic syndrome.

Authors:  Erika P Guedes; Eduardo Madeira; Thiago T Mafort; Miguel Madeira; Rodrigo O Moreira; Laura Maria C Mendonça; Amélio F Godoy-Matos; Agnaldo J Lopes; Maria Lucia F Farias
Journal:  Diabetol Metab Syndr       Date:  2016-12-19       Impact factor: 3.320

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.